Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the closing of a public offering of an ...

President Donald Trump continues to advance his agenda with executive actions ahead of a deadline to impose tariffs on imports from Canada and Mexico this weekend. Follow for live updates.

The most recent trading session ended with Merck (MRK) standing at $98.82, reflecting a -0.13% shift from the previouse trading day's closing. This move was narrower than the S&P 500's daily loss of 0 ...

Merck MRK has decided to stop the phase III HYPERION study early. The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the ...

Facing intense scrutiny from senators over his potential profit from vaccine lawsuits while serving as the nation’s health secretary, Robert F. Kennedy Jr. said that if he ...

Ballard Partners re-upped its agreement to lobby for the Democratic Republic of Congo amid escalating violence in the central ...

Administration Weighs Purge of F.B.I. Agents in Trump-Linked Inquiries President Trump plans to examine scores of agents involved in investigations tied to him and his supporters, according to ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 10, 2024. REUTERS/Brendan McDermid/File Photo U.S. stocks ended lower on Friday, with indexes ...

Global Caprolactam Market. The global caprolactam market is set for significant expansion, with sales expected to grow at a ...

The global immunohistochemistry (IHC) market is expected to grow from USD 3.5 billion in 2024 to USD 7.4 billion by 2034, reflecting a CAGR of 7.8% over the forecast period. Request a Sample Copy of ...